Vice President, Global Program Lead - Hematology Late Development

The Global Program Lead for Hematology Late Development at Bristol Myers Squibb serves as the primary accountability point for two hematology assets, orchestrating the end-to-end strategy from candidate nomination through successful launch. This role involves leading cross-functional global program teams, defining integrated development plans, and aligning clinical and commercial strategies to ensure the approval and commercialization of marketed and novel assets.